Atracurium

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Atracurium
Accession Number
DB13295
Type
Small Molecule
Groups
Approved, Experimental, Investigational
Description
Not Available
Synonyms
Not Available
Categories
UNII
2GQ1IRY63P
CAS number
64228-79-1
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
1,10-PhenanthrolineThe therapeutic efficacy of Atracurium can be decreased when used in combination with 1,10-Phenanthroline.
2,5-Dimethoxy-4-ethylthioamphetamineThe risk or severity of adverse effects can be increased when Atracurium is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
3,4-MethylenedioxyamphetamineThe risk or severity of adverse effects can be increased when 3,4-Methylenedioxyamphetamine is combined with Atracurium.
4-Bromo-2,5-dimethoxyamphetamineThe risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Atracurium.
4-MethoxyamphetamineThe risk or severity of adverse effects can be increased when 4-Methoxyamphetamine is combined with Atracurium.
5-methoxy-N,N-dimethyltryptamineThe risk or severity of adverse effects can be increased when Atracurium is combined with 5-methoxy-N,N-dimethyltryptamine.
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Atracurium.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinolineThe risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Atracurium.
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Atracurium.
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Atracurium.
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Atracurium
ATC Codes
M03AC04 — Atracurium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedNot AvailableIntraocular Pressure1
3CompletedDiagnosticPostoperative pain1
4CompletedDiagnosticAtracurium / Cefazolin / Morphine / Nadroparin / Obese1
4CompletedSupportive CarePost-Operative Nausea and Vomiting (PONV) / Postoperative pain1
4CompletedSupportive CareQuality of Ocular Akinesia (Onset and Duration)1
4CompletedTreatmentTracheal Intubation1
4Not Yet RecruitingOtherPatients Undergoing Laparoscopic Surgery1
Not AvailableCompletedSupportive CareRobot-Assisted Laparoscopic Radical Prostatectomy1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on June 23, 2017 14:39 / Updated on November 02, 2018 07:37